President Trump’s administration is putting real federal muscle behind Lyme disease, and patients who spent years feeling dismissed finally have Washington paying attention.

On May 29, 2026, HHS announced that Secretary Robert F. Kennedy unveiled new initiatives to combat Lyme disease and other tick-borne illnesses.

The New Hampshire stop was part of Kennedy’s Take Back Your Health tour.

This is a MAHA story with teeth: real money, real research, and a prevention plan aimed at one of the most common illnesses in the country.

HHS says Lyme disease affects an estimated 476,000 Americans every year.

ADVERTISEMENT

The agency also says tick-bite emergency room visits have hit their highest springtime level in nearly a decade.

The package includes a multi-million-dollar tick-control pilot, up to $2.5 million in LymeX innovation challenges, new Alpha-gal syndrome research, and a patient-provider connection push.

HHS described the new federal push this way:

HHS actions include a multi-million-dollar pilot program focused on tick control, up to $2.5 million in innovation challenges, funding for NIH researchers to combat Alpha-gal syndrome, and a public-private collaboration to help patients connect with experienced providers.

Secretary Kennedy delivered these announcements during a press conference in New Hampshire, one of the states hardest hit by Lyme disease, after convening a roundtable with state lawmakers and Lyme disease advocates as part of his Take Back Your Health tour.

Millions of Americans battling Lyme disease and other tick-borne illnesses have spent years searching for answers, treatment, and support.

Today, the Trump Administration is launching one of the most ambitious federal efforts ever to combat Lyme disease by accelerating research, expanding innovation, and improving care for patients and families.

We are going after this disease at its source, driving faster diagnostics and new prevention strategies, and delivering the urgency and action Americans deserve.

Kennedy framed the effort as one of the biggest federal swings ever taken at this disease.

ADVERTISEMENT

The prevention side of the plan is especially concrete.

Rather than only talking about treatment after infection, HHS says the new pilot will target ticks on wildlife before they spread disease to humans.

HHS gave the numbers and the target for the tick-control initiative:

Lyme disease remains one of the nation’s fastest-growing vector-borne health threats. More than 476,000 Americans are diagnosed with Lyme disease each year, and recent data show emergency room visits for tick bites reached their highest springtime level in nearly a decade.

As part of the Department’s broader strategy to address tick-borne diseases, HHS announced a new multi-million-dollar pilot program led by the Centers for Disease Control and Prevention (CDC) and HHS in collaboration with leading tick-control researchers.

The initiative will develop and deploy practical strategies to target and eliminate ticks on wildlife before they can spread disease to humans.

The effort will begin with researchers at the New England Center of Excellence in Vector-Borne Diseases and will build on existing community collaboration, including collaboration with the Indian Health Service (IHS) and the Wampanoag Tribe in Massachusetts.

By reducing tick populations and disrupting breeding cycles, the initiative aims to slow disease transmission and protect more Americans from infection.

The Department also reaffirmed its goal of reducing Lyme disease cases by 25 percent by 2035 compared to 2022 levels.

ADVERTISEMENT

The Alpha-gal piece matters too.

That tick-linked condition can leave people allergic to red meat and other mammalian products, and HHS says nearly 500,000 Americans may be living with it.

For Lyme patients specifically, the long-running complaint has been that the medical system waved them off and left them to fight for answers on their own.

That is why the new patient-resource lane matters.

HHS now describes Lyme as an invisible illness problem with major diagnostic and care gaps:

Lyme disease is a tick-borne infection that can lead to chronic, often invisible multi-system illness. Even after treatment, up to 20% of patients may develop Lyme infection-associated chronic conditions and illnesses (Lyme-IACCI) with persistent fatigue, pain, cognitive issues, neurological complications, and other enduring health challenges.

Lyme disease is the most common vector-borne disease in the United States, with an estimated 476,000 Americans diagnosed and treated annually, according to the Centers for Disease Control and Prevention (CDC).

Lyme affects nearly every body system, producing wide-ranging symptoms that frequently overlap with other infections and autoimmune conditions, leading to frequent misdiagnosis or delayed care.

Current diagnostics cannot yet reliably detect all stages of Lyme disease, and many patients continue to experience persistent symptoms even after antibiotics.

ADVERTISEMENT

The economic burden is significant, likely in the billions annually, yet the full cost of illness remains unquantified due to limited research and incomplete data.

Kennedy presented the effort himself at the live event, and HHS pushed the clip out as the announcement went public.

HHS is framing the effort around prevention, research, faster diagnostics, and connecting patients with help.

For the hundreds of thousands of Americans who deal with ticks and Lyme every year, that focus has been a long time coming.

This is a Guest Post from our friends over at WLTReport. View the original article here.

 

Join The Conversation. Leave a Comment.